News & Analysis on Clinical Trial Services & Contract Research And Development
INC Research, Quintiles, Bridge Pharmaceuticals, Charles River Laboratories and PharmaNet have all had people on the move in the world of pharmaceutical outsourcing.
Researchers from Amgen have published results detailing a method that improves the analysis of the sugar groups attached to monoclonal antibodies (MAbs) and proteins.
NanoImaging Services has opened what it claims is a first of its kind fee-for-service imaging business to enable structural characterisation and validation of biological drugs throughout the development pipeline.
Procter & Gamble (P&G) has this week terminated an agreement with Nastech to develop a nasally delivered version of Eli Lilly's osteoporosis drug Forteo (teriparatide), leaving its partner with no explanation for the decision.
This week two sets of contract research organisations (CROs) have announced plans to link arms in order to spread their reach further into this increasingly globalised marketplace.
US-based Aveo Biopharmaceuticals is hoping to prove its R&D strategy can buck high industry failure rates when trying to design new cancer drugs and it seems to be working after its lead drug has passed a first-in-man trial with flying colours.
A US research team has found a way to increase drug distribution in the brain to fight the recurrence of human brain tumours.
Agilent has signed a definitive agreement to acquire automation expert Velocity11 for an undisclosed amount to enable it to speed up drug discovery and genomics research.
US biotechnology company Genentech is filling its trophy cupboard again after being named the winner of the 2007 Facility of the Year Award.
After losing a key Novartis contract and getting caught up in the Inyx collapse, Inventiv Health had good news this week when it reported its third quarter results.